
Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
Annals On Call Podcast
00:00
Understanding Study Outcomes in Type 2 Diabetes Research
This chapter outlines the inclusion criteria for patients in a type 2 diabetes study, focusing on age and medical history. It also details the primary and secondary outcomes of the trial, including mortality and cardiovascular events over a 2.2-year follow-up period.
Transcript
Play full episode